A growing number of developments in the photonics market point to a structural mismatch. Companies are no longer developing only isolated lenses, lasers, optical sensors or specialised laboratory equipment. They are building light-based technology systems that connect materials, semiconductor structures, photonic chips, packaging, electronics, software, calibration methods, data processing and industrial applications.

Photonics is becoming part of the infrastructure of artificial intelligence, data centres, medical diagnostics, industrial manufacturing, autonomous systems, quantum technologies and advanced semiconductor ecosystems. Yet much IP advice is still publicly framed as if the central question were whether a particular optical component, waveguide, sensor or manufacturing process can be patented.

This article is not about whether intellectual property matters in photonics. That question has largely been answered. It is about a gap. On one side, photonics companies operate in layered value chains in which patents, trade secrets, fabrication know-how, testing results, software, standards, supplier relationships, collaboration agreements and freedom to operate increasingly interact. On the other side, visible IP communication frequently separates these issues into individual legal services. Each service is relevant. But photonics companies increasingly need something more integrated.

The core thesis is this: photonics is becoming strategic infrastructure, and IP must evolve from a narrow protection function into a decision system for technological control, collaboration, investment and market access.

The demand side: what photonics companies increasingly need

Photonics companies are not primarily asking whether they can obtain “a patent” for “an optical invention”. Their operational questions are more complex. A silicon photonics company may combine chip architecture, waveguide design, laser integration, electronic drivers, thermal management, testing and fabrication processes. A medical optics company may depend on optical hardware, imaging algorithms, calibration data, diagnostic workflows and regulatory evidence. A LiDAR or depth-sensing company may combine light sources, detectors, scanning architectures, signal processing, software and system integration.

A quantum photonics company may depend on specialised light sources, detectors, optical circuits, communications systems and research collaborations. An industrial metrology company may create value through the interaction of sensing equipment, measurement routines, data interpretation and customer-specific production knowledge.

The strategic question is therefore not only: What can we protect? The better question is: What must we control in order to scale, collaborate, attract investment, preserve freedom to operate and maintain a defensible position in the value chain?

Value may arise in a material composition, a nanostructure, a photonic integrated circuit (PIC) or an optical component. But it may also arise in packaging, coating, calibration, testing, software, signal processing, system integration or the interpretation of optical data. The decisions what to create often arise before an individual patent application is drafted. They concern technology architecture, portfolio design, collaboration models, supplier dependencies and the commercialisation strategy surrounding the technology.

From optical components to industrial infrastructure

The central development in photonics is not simply that optical components are improving. It is that light-based technologies are moving into the operational core of other industries. The transition is particularly visible in AI infrastructure. AI workloads require high-bandwidth and energy-efficient movement of data. NVIDIA’s announcement of photonics-based networking switches for AI factories illustrates how silicon photonics and co-packaged optics are moving from specialised components into large-scale computing infrastructure.

Europe’s PIXEurope initiative reflects the same development from an ecosystem perspective. Its planned open-access pilot line covers fabrication, testing and reliability for photonic integrated circuits across the PIC supply chain. These developments show that photonics innovation cannot be understood by looking only at the final component. The commercially relevant system may extend from materials and chip design through fabrication to software, data processing and customer-specific integration.

Optical interconnects, LiDAR, depth sensing, hyperspectral imaging, medical optics, optical metrology and quantum photonics are therefore not isolated niches. They are enabling use case for industries that depend on bandwidth, precision, energy efficiency, miniaturisation and data quality. For IP Management, this means that protection must reflect layers of the value architecture rather than only visible optical products.

The transition from future promise to decision pressure

For many years, photonics was primarily described as a future technology associated with research institutions, advanced laboratories, specialised components and long development cycles. That perception is changing.

AI requires faster data transfer. Advanced manufacturing requires inline measurement and greater precision. Robotics and autonomous systems require richer perception. Medical diagnostics increasingly use optical measurement and imaging. Quantum technologies depend on highly specialised photonic components and communication systems. Semiconductor ecosystems are exploring photonic integration new platforms. As these applications become commercially actionable, IP decisions acquire greater urgency.

Patent filing trends and the growing number of investment-backed photonics companies indicate that patent portfolios are becoming part of the narrative presented to investors, industrial partners, customers and potential acquirers. In a capital-intensive technology field, a patent portfolio is not merely evidence that inventions have occurred. It can demonstrate technological ownership, barriers to entry and the company’s ability to preserve a position as the market develops.

At the same time, photonics companies face a timing problem. Product and platform cycles can move faster than patent-grant procedures. The appropriate response is not necessarily to file more patents. It is to obtain the right coverage: protection directed at technical control points that are likely to remain strategically relevant even as individual products evolve.

The supply side: what IP communication still often emphasises

When photonics-related IP expertise is publicly presented, the visible emphasis often remains on technical credentials and traditional legal services. Communication may highlight experience in optics, physics, electrical engineering, semiconductor technology, telecommunications or medical devices. It may refer to patent drafting, prosecution, patent portfolio management, freedom-to-operate searches, opposition, litigation, licensing or trade secret policies.

All of these capabilities are necessary. But they can remain fragmented if they are not connected to the strategic control problem faced by the company.

The message is often: We can protect photonics inventions. Much less frequently does the message become: We can help you determine where value, control, dependency and defensibility arise across the photonics system and its value chain. That distinction matters.

A patent covering an optical component may not protect the architecture that makes the component commercially viable. Protection for a photonic chip may not secure the fabrication knowledge needed to achieve sufficient yield. A patent portfolio may cover the visible product while overlooking calibration routines, testing procedures or customer-specific integration.

A proprietary interface may create control but limit ecosystem adoption. An open interface may accelerate scaling but weaken differentiation. A collaboration with a foundry may provide essential manufacturing capabilities while leaving ownership of production process improvements unclear. In photonics, protection choices increasingly become architecture, collaboration and business model choices.

Where the mismatch becomes visible

The gap becomes clearest when comparing the situations photonics companies face with the way IP expertise is often segmented. A photonics company does not experience its risks in separate legal boxes. It experiences its technology and value chain as one decision environment.

The engineering logic asks whether the system achieves the required optical performance, reliability and manufacturing yield. The patent logic asks which technical functions can be claimed and enforced. The trade secret logic asks which process parameters, tolerances, calibration methods and testing routines can remain confidential. The collaboration logic asks who owns background technology, jointly created results and subsequent improvements. The FTO logic asks whether the architecture can be commercialised without unacceptable legal exposure. The standards logic asks how interoperability and market convergence may affect market access and bargaining power. The supply chain logic asks where dependence on materials, substrates, equipment, foundries and specialised components arises. The investment logic asks whether the company has built a durable and commercially meaningful control position.

When these logics are treated separately, a company may receive legally correct advice and still remain strategically exposed. It may patent a device architecture but fail to protect the concrete solution required for industrial use. It may retain fabrication details as trade secrets without establishing the governance needed to preserve confidentiality across employees, suppliers and international partnerships. It may secure ownership of the original technology but fail to regulate improvements created with a university, foundry, customer or equipment supplier. It may possess a large patent portfolio while remaining dependent on a critical platform or manufacturing process controlled by another party. The company may therefore own valuable IP and still lack strategic control.

Patent portfolios must follow the layers of value

Photonics systems can combine materials, nanostructures, waveguides, light sources, detectors, electronic drivers, thermal management, software, signal processing, calibration data and testing procedures. The final product may be easy to describe. The economically relevant control points may not be.

A portfolio must therefore be designed around the layers through which value is created and captured. This requires decisions about which system functions should be patented, which manufacturing parameters should remain confidential, which interfaces may become strategically important and which implementation paths could shape future technological standards.

Patent claims must also reflect how competitors are likely to enter the market. Protection directed only at the final product may be insufficient when the decisive activity occurs at the level of a supplier, foundry, software platform or system integrator. The purpose of a patent portfolio architecture is not simply to accumulate rights. It is to establish meaningful exclusivity across the technical and commercial structure of the business.

The patent-versus-trade-secret gap

Photonics creates a particularly difficult relationship between patents and trade secrets. Some innovations can be discovered through product analysis or reverse engineering. In those cases, patent protection may be necessary to create an enforceable position. Other advantages lie in process parameters, coating methods, tolerances, calibration routines, manufacturing recipes, testing approaches or yield optimisation. These may be difficult to observe from the final product and can therefore be suitable for trade secret protection. But the decision cannot be made invention by invention in isolation.

Trade secrets may become fragile when a company scales internationally, cooperates with external manufacturers, experiences employee mobility, seeks investment or must disclose information to customers and regulatory bodies. Patenting everything, by contrast, may disclose valuable process knowledge without producing commercially useful claim coverage. Photonics companies therefore need a coordinated patent and trade secret architecture.

The question is not which instrument is generally superior. The question is which combination supports the business model, product roadmap, enforcement environment and collaboration structure. Often this leads to balanced strategies involving selective but strategically focused patent filings rather than reliance on secrecy alone.

Product-based freedom to operate (FTO) becomes system and value chain FTO

Freedom to operate (FTO) in photonics cannot always be reduced to a patent search covering one component. Photonics systems frequently combine established technologies with new materials, devices, software and integration methods. Foundational rights may sit in universities, research organisations, acquired companies, legacy portfolios, component suppliers or specialised manufacturing partners. A meaningful FTO assessment may therefore need to consider materials, photonic devices, chip architectures, manufacturing and testing equipment, electronic integration, software, signal processing, communication interfaces and standards.

The risk may sit in the visible product. But it may also sit in a supplier-controlled component, fabrication platform or technical interface. FTO should therefore enter technical decision-making before the architecture becomes fixed. It can influence design choices, sourcing, partnership structures, licensing discussions and participation in standardisation. It should also be connected to product roadmaps, because later changes of materials, software or system integration may create new exposure.

The relevant question is not simply whether one optical component infringes a patent. The company must understand whether the complete technical and commercial architecture can be manufactured, deployed, maintained and scaled without unacceptable dependencies.

Collaboration becomes an IP infrastructure question

Photonics innovation is rarely created by one actor alone. It frequently emerges through cooperation between universities, research institutes, startups, foundries, materials providers, equipment manufacturers, packaging specialists, system integrators, industrial customers, investors and standard-setting organisations. This is particularly visible in photonic integrated circuits, where design, fabrication, packaging and testing may be distributed across several organisations. IP consequently becomes cooperation infrastructure.

It must clarify what each participant contributes, which background rights remain with each party, what is created jointly, who may commercialise the results and how later product generations or process improvements may be developed. Without this structure, collaboration may accelerate technical progress while weakening strategic control.

Contracts must therefore address more than formal IP ownership. They must regulate access, fields of use, confidentiality, licensing, manufacturing rights, improvements and future commercialisation. They should also anticipate how a research project, pilot line or customer-specific development may evolve into an industrial platform. This is especially important for university spin-offs and specialised deep-tech companies with limited budgets. Filing and ownership decisions must be linked to funding milestones, partnership negotiations, commercialisation pathways and future bargaining leverage.

Standards and interfaces become competitive control points

Optical communication, AI infrastructure, automotive sensing and industrial systems depend on technical interfaces and interoperability. As markets converge around standards or dominant design architectures, IP positions may influence access, implementation choices and negotiating power. A company must therefore decide which interfaces should remain proprietary, which should be licensed and which may need to be standardised to support ecosystem adoption.

Implementation path patents can become particularly important. Even where a function is required by a standard or market architecture, alternative technical implementations may exist. Rights covering commercially attractive implementation paths can influence design choices and competitive positioning. Standards strategy should therefore not be treated as a separate legal topic introduced only after technologies have matured. It must be connected to portfolio development, competitor monitoring, licensing and product architecture.

The supply chain control gap

Photonics depends on specialised materials, substrates, fabrication equipment, components, packaging capabilities and manufacturing knowledge. A company may control the visible product while depending on third parties for critical process steps or material platforms. This creates a gap between apparent patent portfolio strength and actual strategic independence. A patent count does not reveal whether the company can manufacture without a particular supplier, transfer production to another foundry, substitute a critical material or preserve quality during scaling. The IP strategy must therefore reflect supply chain architecture.

Companies need to identify where process knowledge sits, which supplier relationships relate to essential rights, whether alternative manufacturing routes exist and whom improvements made by suppliers will be assigned to. Trade secret governance, contractual access rights, patent ownership and supplier diversification must work together. Otherwise, the company may build a strong product portfolio while leaving the underlying protection capability outside its control.

Photonics is expanding across industrial systems

The breadth of photonics-related patent disputes and patent office activity already demonstrates how widely the field has spread. Recent filings have covered subject matter across displays, imaging, sensors, medical applications, optical communications, augmented and virtual reality, wearable optical devices and laser-based manufacturing. This diversity is strategically important.

Photonics cannot be approached as one homogeneous technology category. The relevant control point differs by application. In AI infrastructure, it may lie in optical interconnects, co-packaged optics or photonic integrated circuits. In industrial manufacturing, it may lie in precision measurement, inline inspection, laser processing or calibration. In medical applications, value may arise from the interaction of optics, imaging, data interpretation and diagnostic workflows. In autonomous systems, it may lie in LiDAR, depth sensing or hyperspectral perception. In quantum technologies, it may depend on specialised sources, detectors, optical circuits and communication architectures.

The IP approach must consequently reflect both the common photonics platform and the specific commercial system in which it is deployed.

New uncertainty gaps

The uncertainty facing photonics companies is not only legal. It is strategic. Where does value arise: in the material, device, chip design, fabrication process, packaging, calibration routine, software, dataset, interface or customer-specific integration? Where does dependence arise: in a foundry, substrate, equipment supplier, component manufacturer, research partner, standard or proprietary manufacturing platform? Where does risk arise: in patent infringement, weak confidentiality, unclear IP ownership in collaborations, supplier lock-in, standards, limited manufacturing access or an inability to enforce rights against the commercially relevant actors?

These questions cannot be answered only after the technical development has been completed. Early architecture choices determine later IP options. A decision to integrate a laser on-chip or use an external source may alter patent exposure and supplier dependence. A decision to insource or outsource packaging may determine where process knowledge accumulates. A decision to disclose technical details in research publications may affect patentability and trade secret protection. A company that treats IP only as a filing step may discover too late that its most important control points were never captured.

Why fragmented IP advice is not enough

The IP advisory market is commonly organised around separate services: patent drafting, prosecution, freedom to operate, oppositions, litigation, licensing, contracts, trade secret management, standardisation advice and due diligence. Each discipline is necessary. But a photonics business is not a collection of unrelated legal tasks. It is a connected architecture of technology, manufacturing, software, collaboration, supply chains, investment and market access.

A startup developing a photonic AI accelerator does not only need a patent application. It must determine which architectural features will remain relevant across product cycles, which manufacturing innovations should stay secret, whether packaging creates FTO risks, how foundry collaboration affects IP ownership and what investors will expect the portfolio to demonstrate.

An established industrial company using optical sensing does not only need clearance for one product feature. It must determine whether the defensible asset is the sensor, calibration routine, data model, machine integration, service or customer-specific process knowledge. Each answer leads to a different IP strategy. The role of the IP expert is therefore broader than explaining individual protection rights. It is to create decision capability.

A gap in translation

What appears is not primarily a lack of legal or technical expertise. It is a gap in translation. Photonics companies increasingly experience IP through questions of technological control, manufacturing access, investment, collaboration, supply chain resilience, standards, scalability and market entry. Publicly visible IP expertise often continues to describe the field through separate categories such as patents, trade secrets, FTO, contracts, licensing and litigation. Those categories are necessary. But they are not the same as the strategic problems experienced by the company.

The opportunity for IP experts is therefore not merely to offer more photonics expertise. It is to make existing expertise legible as integrated decision support. Companies need to understand where the defensible control point lies. In one case, it may be a materials platform. In another, a waveguide architecture. In another, a packaging process, calibration routine, testing procedure or implementation path. In yet another case, the strategic position may depend on combining patents, trade secrets, manufacturing know-how and contractual rights. The next step is to translate this complexity into management choices.

The strategic opportunity

The market opportunity is not simply to tell photonics companies that IP is important. Many already know that. The opportunity is to demonstrate how IP can function as a decision system for light-based innovation.

It can help management determine:

  • which layers of the technology should be patented;
  • which process knowledge should remain confidential;
  • which interfaces should be opened, licensed or kept exclusive;
  • where FTO analysis may influence technical architecture pathways;
  • how IP ownership in collaborations should be structured;
  • which supplier dependencies must be reduced;
  • how patent portfolios can support investment and partnership decisions; and
  • where enforcement and negotiation leverage can realistically arise.

That is where the next stage of differentiation in photonics IP advice may begin.

Companies that understand this early gain room to act. They can design IP portfolios around layers of value rather than isolated inventions. They can manage patents and trade secrets as a coordinated system. They can integrate FTO and standards considerations before technical architecture becomes locked in. They can structure collaborations without losing control over future development. They can also use IP to explain to investors and partners not only what the company has invented, but why it possesses a durable position in the emerging value chain.

Companies that treat IP reactively face a different risk. They may become technologically advanced but dependent on external fabrication. Patent-active but exposed at the system level. Rich in know-how but unable to preserve confidentiality. Collaborative but weak in IP ownership negotiations. Present in a growing market but unable to control the layers through which commercial value is captured.

The photonics strategy gap is therefore not a gap between light-based technologies and intellectual property. It is a gap between connected photonics ecosystems and fragmented IP advisory narratives. Closing that gap means translating IP expertise into the language of strategic control over the technologies, processes, partnerships and infrastructures through which light is becoming an industrial platform.